1. |
Clowse ME, Harward L, Criscione-Schreiber L, et al. Anti-Müllerian hormone:a better marker of ovarian damage from cyclophosphamide[J]. Arthritis Rheum, 2012, 64(5):1305-1310.
|
2. |
Sowers MR, Eyvazzadeh AD, McConnell D, et al. Anti-Müllerian hormone and inhibin B in thedefinition of ovarian aging and the menopause transition[J]. J Clin Endoc Metab, 2008, 93(9):3478-3483.
|
3. |
Visser JA, de Jong FH, Laven JS, et al. Anti-Müllerian hormone:a new marker for ovarian function[J]. Reproduction, 2006, 131(1):1-9.
|
4. |
McDermott EM, Powell RJ. Incidence of ovarian failure in systemic lupus erythematosus after treatment with pulse cyclophosphamide[J]. Ann Rheum Dis, 1996, 55(4):224-229.
|
5. |
Warne GL, Fairley KF, Hobbs JB, et al. Cyclophosphamide-induced ovarian failure[J]. N Engl J Med, 1973, 289(22):1159-1162.
|
6. |
Petri M. Systemic Lupus International Collaborating Clinic (SLICC):SLICC revision of the ACR classification criteria for SLE[J]. Arthritis Rheum, 2009, 60(Suppl 10):895.
|
7. |
Weenen C, Laven JS, von Bergh AR, et al. Anti-Müllerian hormone expression pattern in the human ovary:potential implications forinitial and cyclic follicle recruitment[J]. Mol Hum Reprod, 2004, 10(2):77-83.
|
8. |
Pigny P, Jonard S, Robert Y, et al. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 2006, 91(3):941-945.
|
9. |
Mok CC, Chan PT, To CH. Anti-Müllerian hormone and ovarian reserve in systemic lupus erythematosus[J]. Arthritis Rheum, 2013, 65(1):206-210.
|
10. |
李艳梅, 赵义, 慈春增, 等. 抗缪勒管激素在女性系统性红斑狼疮中的临床意义及与抗卵巢细胞抗体的关系[J]. 中华风湿病学杂志, 2010, 14(5):305-307.
|
11. |
Lawrenz B, Henes JC, Henes M, et al. Impact of systemic lupus erythematosus on ovarian reservein premenopausal women:evaluation by using anti-Müellerian hormone[J]. Lupus, 2011, 20 (11):1193-1197.
|